Literature DB >> 280401

Razoxane in treatment of acute myeloid leukaemia.

D Shaw, G R Tudhope.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 280401      PMCID: PMC1608192          DOI: 10.1136/bmj.2.6144.1089-d

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  3 in total

1.  Quality and quantity of survival in acute myeloid leukaemia.

Authors:  P S Burge; T A Prankerd; J D Richards; M Sare; D S Thompson; P Wright
Journal:  Lancet       Date:  1975-10-04       Impact factor: 79.321

2.  High remission-induction rate in acute myeloid leukaemia.

Authors:  R P Gale; M J Cline
Journal:  Lancet       Date:  1977-03-05       Impact factor: 79.321

3.  Treatment of acute myeloid leukaemia with a triple cytotoxic regime: DAT.

Authors:  J K Rees; R M Sandler; J Challener; F G Hayhoe
Journal:  Br J Cancer       Date:  1977-12       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.